Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Hologic Inc.

    NASDAQ: HOLX · Real-Time Price · USD
    67.28
    -0.53 (-0.78%)
    At close: Aug 18, 2025, 3:59 PM
    68.68
    2.08%
    After-hours: Aug 18, 2025, 05:49 PM EDT
    -0.78%
    Bid 67.27
    Market Cap 14.96B
    Revenue (ttm) 4.04B
    Net Income (ttm) 557.1M
    EPS (ttm) 2.41
    PE Ratio (ttm) 27.92
    Forward PE 15.09
    Analyst Hold
    Ask 69.51
    Volume 1,461,325
    Avg. Volume (20D) 2,609,511
    Open 69.03
    Previous Close 67.81
    Day's Range 67.28 - 69.03
    52-Week Range 51.90 - 84.39
    Beta 0.49

    About HOLX

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol HOLX
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for HOLX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    Hologic Inc. is scheduled to release its earnings on Nov 3, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription
    2 weeks ago
    +0.51%
    HOLX stock has given up its prior gain. Hologic sh... Unlock content with Pro Subscription
    2 weeks ago
    +0.51%
    Hologic shares are trading higher after Morgan Stanley and UBS raised their respective price targets on the stock.
    news image

    3 days ago · zacks.com

    Is Trending Stock Hologic, Inc. (HOLX) a Buy Now?

    Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

    news image

    5 days ago · zacks.com

    Hologic Eyes Organic Growth Rebound in 2026 on Breast Health Strength

    HOLX targets a mid-single-digit organic growth rebound in 2026, powered by Breast Health recovery and new product innovation.

    news image

    1 week ago · zacks.com

    Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It?

    HOLX's Diagnostics arm eyes long-term growth with new assays, platform expansion and oncology test adoption despite headwinds.

    news image

    1 week ago · zacks.com

    Should You Buy, Sell or Hold Hologic Stock Post Q3 Earnings?

    HOLX rises post earnings beat, fueled by Diagnostics strength and Surgical growth. However, macro headwinds persist.

    news image

    2 weeks ago · zacks.com

    Why Hologic (HOLX) is a Top Value Stock for the Long-Term

    Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

    news image

    2 weeks ago · zacks.com

    Interpreting Hologic (HOLX) International Revenue Trends

    Evaluate Hologic's (HOLX) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

    news image

    2 weeks ago · zacks.com

    Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know

    Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

    news image

    2 weeks ago · zacks.com

    Hologic Stock Falls Despite Q3 Earnings and Revenue Beat, Margins Down

    HOLX posts better-than-expected Q3 results, but margin contraction and regional headwinds pressure investor sentiment.

    news image

    2 weeks ago · fool.com

    Hologic (HOLX) Q3 Revenue Beats 1%

    Hologic (HOLX) Q3 Revenue Beats 1%

    news image

    2 weeks ago · seekingalpha.com

    Hologic, Inc. (HOLX) Q3 2025 Earnings Call Transcript

    Hologic, Inc. (NASDAQ:HOLX ) Q3 2025 Earnings Conference Call July 30, 2025 4:30 PM ET Company Participants Essex D. Mitchell - Chief Operating Officer Karleen M.

    Add to Watchlist